People · Operator
Named in public records as an officer, director or promoter · active 2015–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pyramid Biosciences, Inc. | — | Biotechnology | Series B | $52.0M | $778.5M | 2021 |
| KnipBio, Inc. | — | Other Technology | Seed | $7.3M | $3.6M | 2015 |
Larry Feinberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Larry Feinberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jessica McLear | 1 | 3 |
| John Childs | 1 | 3 |
| Kollol Pal | 1 | 2 |
| Vladimir Coric | 1 | 2 |
| Jeremy Weinstein | 1 | 1 |
| Jordan Leef | 1 | 1 |
| Lucien Agniel | 1 | 1 |
| Christopher Marx | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.